Keywords
pancreatic diseases, stages of progression, risk factors, pathogenesis, treatment
How to Cite
Gubergrits, N. B., Lukashevich, G. M., Fomenko, P. G., & Byelyayeva, N. V. (2017). “Fatal chain”: from acute pancreatitis to pancreatic cancer. Herald of Pancreatic Club, 36(3), 16-29. https://doi.org/10.33149/vkp.2017.03.02
Abstract views: 335 PDF Downloads: 344 PDF Downloads: 109
Abstract
The article provides a review of literature on the "fatal chain" in pancreatology. This refers to the links starting from acute pancreatitis to its relapse, development of chronic pancreatitis, pancreatic fibrosis progression and increasing risk of pancreatic adenocarcinoma (similar to the "fatal chain" in hepatology: from acute to chronic hepatitis, cirrhosis and liver cancer). Logical links are confirmed by the literature data and results of the evidence-based research. Preventive and curative actions aimed to interrupt "fatal chain" are discussed.
References
1. Корочанская Н. В. Хирургическая и медикаментозная профилактика раковой трансформации осложненного хронического панкреатита / Н. В. Корочанская, М. Л. Рогаль, И. Ю. Гришина // Гастро News. ― 2008. ― № 5. ― С. 4650.
2. Корочанская Н. В. Хирургическая и медикаментозная профилактика раковой трансформации хронического панкреатита / Н. В. Корочанская, М. Л. Рогаль, И. Ю. Гришина. ― М. : 4ТЕ АРТ, 2008. ― 56 с.
3. Мудрые мысли о медицине и врачевании: изречения, афоризмы, цитаты / автор композиции Я. С. Циммерман. – 4-е изд., доп. – М. : ГЭОТАР-Медиа, 2015. – 256 с.
4. Практическая гепатология / под ред. акад. РАМН Н. А. Мухина // Материалы «Школы гепатолога», проводимой на базе клиники нефрологии, внутренних и профессиональных заболеваний им. Е. М. Тареева ММА им. И. М. Сеченова. – М., 2004. – 294 с.
5. Alcohol and cigarette smoke components activate human pancreatic stellate cells: implications for the progression of chronic pancreatitis / A. T. Lee, Z. Xu, S. P. Pothula [et al.] // Alcohol. Clin. Exp. Res. – 2015. – Vol. 39, No 11. – P. 2123–2133.
6. Alcohol consumption and site-specific cancer risk : a comprehensive dose-response meta-analysis / V. Bagnardi, M. Rota, E. Botteri [et al.] / Br. J. Cancer. –2015. – Vol. 112, No 3. – P. 580–593.
7. Alcohol intake and pancreatic cancer : a pooled analysis from the pancreatic cancer cohort consortium (PanScan) / D. S. Michaud, L. Jiao [et al.] // Cancer Causes Control. – 2010. – Vol. 21, No 8. – P. 1213–1225.
8. And the American College of Gastroenterology. American College of Gastroenterology guideline : management of acute pancreatitis / S. Tenner, J. Baillie, J. DeWitt, S. S. Vege // Am. J. Gastroenterol. – 2013. – Vol. 108. – P. 1400–1416.
9. And the European Society of Gastrointestinal Endoscopy. European Society of Gastrointestinal Endoscopy (ESGE) Guideline: prophylaxis of post-ERCP pancreatitis / J. M. Dumonceau, A. Andriulli, J. Deviere [et al.] // Endoscopy. – 2010. – Vol. 42. – P. 503–515.
10. And the U.S. Cooperative for Outcomes Research in Endoscopy (USCORE). A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis / B. J. Elmunzer, J. M. Scheiman, G. A. Lehman [et al.] // N. Engl. J. Med. – 2012. – Vol. 366. – P. 1414–1422.
11. Apte M. Pancreatic stellate cell: physiologic role, role in fibrosis and cancer / M. Apte, R. C. Pirola, J. S. Wilson // Curr. Opin. Gastroenterol. – 2015. – Vol. 31, No 5. – P. 416–423.
12. Aspects of medical history and exocrine carcinoma of the pancreas: a population-based case-control study in the Netherlands / H. B. Bueno de Mesquita, P. Maisonneure, C. J. Moerman, A. M. Walker // Int. О. Cancer. ― 1992. ― Vol. 52. ― P. 1723.
13. Augustine P. Is tropical pancreatitis premalignant? / P. Augustine, H. Ramesh // Am. J. Gastroenterol. ― 1992. ― Vol. 87. ― P. 10051008.
14. Brentnall T. A. Management strategies for patients with hereditary pancreatic cancer / T. A. Brentnall // Curr. Treat. Options Oncol. ― 2005. ― Vol. 6. ― P. 437445.
15. Burden of gastrointestinal disease in the United States : 2012 update / A. F. Peery, E. S. Dellon, J. Lund [et al.] // Gastroenterology. – 2012. – Vol. 143. – P. 1179–1187, e1–3.
16. Cachexia in patients with chronic pancreatitis and pancreatic cancer: impact on survival and outcome / J. Bachmann, M. W. Buchler, H. Friess, M. E. Martignoni // Nutr. Cancer. – 2013. – Vol. 65, No 6. – P. 827–833.
17. Cancer risk in nontransplanted and transplanted cystic fibrosis: a 10-year study / P. Maisonneuve, S. C. FitzSimmons, J. P. Neglia [et al.] // J. Natl. Cancer Inst. ― 2003. ― Vol. 95. ― P. 381387.
18. Can early precut implementation reduce endoscopic retrograde cholangiopancreatography-related complication risk? Meta-analysis of randomized controlled trials / V. Cennamo, L. Fuccio, R. M. Zagari [et al.] // Endoscopy. – 2010. – Vol. 42. – P. 381–388.
19. Cardiovascular risk (CVR) associated with pancreatic exocrine insufficiency (PEI) in patients with chronic pancreatitis / N. Vallejo-Senra, De la Inglesia-Garsia, A. Lopez-Lopez [et al.] // Pancreatology. – 2016. – Vol. 16, No 3S1. – P. S80.
20. Cigarette smoking accelerates progression of alcoholic chronic pancreatitis / P. Maisonneuve, A. B. Lowenfels, B. Mullhaupt [et al.] // Gut. ― 2005. ― Vol. 54, No 4. ― P. 510–514.
21. Cigarette smoking, smoking cessation and acute pancreatitis : a prospective population-based study / O. Sadr-Azodi, A. Andren-Sandberg, N. Orsini, A. Wolk // Gut. – 2012. – Vol. 61. – P. 262–267.
22. Complications of single-balloon enteroscopy : a prospective evaluation of 166 procedures / H. Aktas, L. de Ridder, J. Haringsma [et al.] // Endoscopy. – 2010. – Vol. 42. – P. 365–368.
23. A critical analysis of the clinical use of incretin-based therapies: are the GLP-1 therapies safe? / P. C. Butler, M. Elashoff, R. Elashoff, E. A. Gale // Diabetes Care. – 2013. – Vol. 36. – P. 2118–2125.
24. Cystic fibrosis transmembrane regulator (CFTR) DeltaF508 mutation and ST allele in patients with chronic pancreatitis and exocrine pancreatic cancer. PANKRAS II Study Group / N. Malats, T. Casals, M. Porta [et al.] // Gut. ― 2001. ― Vol. 48. ― P. 7074.
25. Cystic fibrosis transmembrane regulator gene carrier status is a risk factor for young onset pancreatic adenocarcinoma / R. McWilliams, W. E. Highsmith, K. G. Rabe [et al.] // Gut. ― 2005. ― Vol. 54. ― P. 16611662.
26. Dai H. F. Role of nonsteroidal anti-inflammatory drugs in the prevention of post-ERCP pancreatitis : a meta-analysis / H. F. Dai, X. W. Wang, K. Zhao // Hepatobiliary Pancreat. Dis. Int. – 2009. – Vol. 8. – P. 11–16.
27. The different courses of early- and late-onset idiopathic and alcoholic chronic pancreatitis / P. Layer, H. Yamamoto, L. Kalthoff [et al.] // Gastroenterology. ― 1994. ― Vol. 107, No 5. ― P. 1481–1487.
28. DiMagno M. J. Pancreas divisum does not cause pancreatitis, but associates with CFTR mutations / M. J. DiMagno, E. P. Dimagno // Am. J. Gastroenterol. – 2012. – Vol. 107. – P. 318–320.
29. Disease progression of acute pancreatitis in pediatric patients / F. Hao, H. Guo, Q. Luo, C. Guo // J. Surg. Res. – 2016. – Vol. 202, No 2. – P. 422–427.
30. Dominguez-Munoz J. E. Survival of patients with unresectable pancreatic cancer: impact of the treatment of pancreatic exocrine insufficiency and malnutrition / J. E. Dominguez-Munoz, L. Nieto, J. Iglesias-Garcia // Pancreatology. – 2013. – Vol. 13, Issue 4. – P. e5.
31. Drug-induced pancreatitis // C. Nitsche, S. Maertin, J. Scheiber [et al.] // Curr. Gastroenterol. Rep. – 2012. – Vol. 14. – P. 131–138.
32. European Registry of Hereditary Pancreatitis and Pancreatic Cancer (EUROPAC). Clinical and genetic characteristics of hereditary pancreatitis in Europe / N. Howes, M. M. Lerch, W. Greenhalf [et al.] // Clin. Gastroenterol. Hepatol. ― 2004. ― Vol. 2. ― P. 5261.
33. Exocrine and endocrine pancreatic insufficiency after acute pancreatitis / M. Vujasinovic, B. Tepes, J. Makuc [et al.] // Pancreatology. – 2013. – Vol. 13, No 3S. – P. S65.
34. For the Dutch Pancreatitis Study Group. Timing of cholecystectomy after mild biliary pancreatitis / O. J. Bakker, H. C. van Santvoort, J. C. Hagenaars [et al.] // Brit. J. Surg. – 2011. – Vol. 98. – P. 1446–1454.
35. Frequency of K-ras mutations in pancreatic intraductal neoplasias associated with pancreatic ductal adenocarcinoma and chronic pancreatitis : a meta-analysis / M. Lohr, G. Kloppel, P. Maisonneuve [et al.] // Neoplasia. ― 2005. ― Vol. 7. ― P. 1723.
36. Gallstones, cholecystectomy and risk of cancers of the liver, biliary tract and pancreas / W. H. Chow, C. Johansen, G. Gridley [et al.] // Br. J. Cancer. –1999. –Vol. 79, No 3–4. – P. 640–644.
37. Garg P. K. Is biliary microlithiasis a significant cause of idiopathic recurrent acute pancreatitis? A long-term follow-up study / P. K. Garg, P. K. Tandon, K. Madan // Clin. Gastroenterol. Hepatol. – 2007. – Vol. 5, No 1. – P. 75–79.
38. Gotian A. Pancreatitis associated with Crohn's disease: a premalignant state for cystadenocarcinoma of pancreas? / A. Gotian, S. Katz // Am. J. Gastroenterol. – 1999. – Vol. 94, No 8. – P. 2301–2302.
39. Gradirian P. Tobacco, alcohol, and coffee and саncer of the pancreas. A population-based, case-control study in Quebec, Canada / P. Gradirian, A. Simard, J. Baillargeon // Cancer. ― 1991. ― Vol. 67. ― P. 26642670.
40. Gullo L. Effect of cessation of alcohol use on the course of pancreatic dysfunction in alcoholic pancreatitis / L. Gullo, L. Barbara, G. Labo // Gastroenterology. ― 1988. ― Vol. 95, No 4. ― P. 1063–1068.
41. Heavy smoking is associated with lower age at first episode of acute pancreatitis and a higher risk of recurrence / S. Munigala, D. L. Conwell, A. Gelrud, B. Agarwal // Pancreas. – 2015. – Vol. 44, No 6. – P. 876–881.
42. Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group / A. B. Lowenfels, P. Maisonneuve, E. P. DiMango [et al.] // J. Natl. Cancer Inst. ― 1997. ― Vol. 89. ― P. 442446.
43. Incidence of cancer in the course of chronic pancreatitis / G. Talamini, M. Falconi, C. Bassi [et al.] // Am. J. Gastroenterol. ― 1999. ― Vol. 94. ― P. 12531260.
44. Increased risk of acute pancreatitis and biliary disease observed in patients with type 2 diabetes : a retrospective cohort study / R. A. Noel, D. K. Braun, R. E. Patterson, G. L. Bloomgren // Diabetes Care. – 2009. – Vol. 32. – P. 834–838.
45. Increased risk of acute pancreatitis in patients with type 2 diabetes : an observational study using a Japanese hospital database / H. Urushihara, M. Taketsuna, Y. Liu [et al.] // PLoS One. – 2012. – Vol. 7. – P. e53224.
46. Indomethacin treatment of acute experimental pancreatitis in the rat / P. G. Lankisch, H. Koop, K. Winckler [et al.] // Scand. J. Gastroenterol. – 1978. – Vol. 13. – P. 629–633.
47. Indomethacin treatment of acute pancreatitis. A controlled double-blind trial / N. Ebbehoj, J. Friis, L. B. Svendsen [et al.] // Scand. J. Gastroenterol. – 1985. – Vol. 20. – P. 798–800.
48. Insulin dependence and pancreatic enzyme replacement therapy are independent prognostic factors for long-term survival after operation for chronic pancreatitis / M. Winny, V. Paroglou, H. Bektas [et al.] // Surgery. – 2014. – Vol. 155, No 2. – P. 271–279.
49. Lankisch P. G. Acute pancreatitis / P. G. Lankisch, M. Apte, P. A. Banks // The Lancet. – 2015. – Vol. 386, No 9988. – P. 85–96.
50. Lankisch P. G. What is the risk of alcoholic pancreatitis in heavy drinkers? / P. G. Lankisch, A. B. Lowenfels, P. Maisonneuve // Pancreas. – 2002. – Vol. 25. – P. 411–412.
51. Lohr J. M. Synopsis of recent guidelines on pancreatic exocrine insufficiency / J. M. Lohr, M. R. Oliver, L. Frulloni // United Eur. Gastroenterol. J. – 2013. – Vol. 1, No 2. – Р. 79–83.
52. Long-term follow-up of patients with chronic pancreatitis and K-ras gene mutation detected in pancreatic juice / N. Furuya, S. Kawa, T. Akamatsu, K. Furihata // Gastroenterology. ― 1997. ― Vol. 113. ― P. 593598.
53. Lowenfels A. B. What is the risk of biliary pancreatitis in patients with gallstones? / A. B. Lowenfels, P. G. Lankisch, P. Maisonneuve. – Gastroenterology. – 2000. – Vol. 119. – P. 879–880.
54. Low incidence of hyperamylasemia after proximal double-balloon enteroscopy: has the insertion technique improved? / H. Aktas, P. B. Mensink, J. Haringsma, E. J. Kuipers // Endoscopy. – 2009. – Vol. 41. – P. 670–673.
55. Masclee Ad A.M. Pancreatic exocrine insufficiency after acute pancreatitis / Ad A. M. Masclee, T. Symersky // Asian Pacific digestive disease week 2005. Proceedings of a Solvay satellite symposium. – 27 September 2005. – Seoul, Korea. – P. 9–12.
56. Mortality in patients with chronic pancreatitis (CP) with and without exocrine pancreatic insufficiency (EPI) / N. Vallejo-Senra, J. Iglesias-Garcia, J. Larino-Noia [et al.] // Pancreatology. – 2015. – Vol. 15, Issue 3. – S12–S13.
57. Natural history of acute pancreatitis: a long-term population-based study / P. G. Lankisch, N. Breuer, A. Bruns [et al.] // Am. J. Gastroenterol. – 2009. – Vol. 104, No 11. – P. 2797–2805.
58. Nauck M. A. A critical analysis of the clinical use of incretin-based therapies: the benefits by far outweigh the potential risks / M. A. Nauck // Diabetes Care. – 2013. – Vol. 36. – P. 2126–2132.
59. Otsuki M. Chronic pancreatitis in Japan: epidemiology, prognosis, diagnostic criteria, and future problems / M. Otsuki // J. Gastroenterol. ― 2003. ― Vol. 38. ― P. 315326.
60. Pancreas – pathological practice and research / Ed. K. Suda. – Basel [et al.] : Karger, 2007. – 318 p.
61. Pancreas cancer and smoking, beverage consumption, and past medical history / T. M. Mack, M. C. Yu, R. Hanisch, B. E. Henderson // О. Natl. Cancer Inst. ― 1986. ― Vol. 76. ― P. 4960.
62. Pancreas divisum is not a cause of pancreatitis by itself but acts as a partner of genetic mutations / C. Bertin, A. L. Pelletier, M. P. Vullierme [et al.] // Am. J. Gastroenterol. – 2012. – Vol. 107. – P. 311–317.
63. Pancreatic carcinoma developing in chronic pancreatitis: a report of four cases / O. Haas, G. Guillard, P. Rat [et al.] // Hepatogastroenterology. ― 1990. ― Vol. 37. ― P. 350–351.
64. Pancreatic carcinoma in chronic pancreatitis with inflammatory tumor of the head of the pancreas / W. Schlosser, M. H. Schoenberg, E. Rhein [et al.] // Gastroenterol. ― 1996.― Vol. 34. ― P. 3–8.
65. Pancreatitis and the risk of pancreatic cancer / E. Fernandez, C. La Vecchia, M. Porta [et al.] // Pancreas. ― 1995. ― Vol. 11. ― P. 185189.
66. Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group / A. B. Lowenfels, P. Maisonneuve, G. Cavallini [et al.] // N. Engl. О. Med. ― 1993. ― Vol. 328. ― P. 14331437.
67. Patients with type 2 diabetes mellitus have higher risk for acute pancreatitis compared with those without diabetes / C. J. Girman, T. D. Kou, B. Cai [et al.] // Diabetes Obes. Metab. – 2010. – Vol. 12. – P. 766–771.
68. Predictive factors for pancreatic cancer in patients with chronic pancreatitis in association with K-ras gene mutation / M. Arvanitakis, J. L. Van Laethem, J. Parma [et al.] // Endoscopy. ― 2004. ― Vol. 36. ― P. 535542.
69. Prognosis of chronic pancreatitis : an international multicenter study. International Pancreatitis Study Group / A. B. Lowenfels, P. Maisonneuve, G. Cavallini [et al.] // Am. J. Gastroenterol. ― 1994. ― Vol. 89. ― P. 14671471.
70. Prophylactic pancreatic stent placement and post-ERCP pancreatitis : an updated meta-analysis / T. Mazaki, K. Mado, H. Masuda, M. Shiono // J. Gastroenterol. – 2013. – Vol. 49. – P. 343–355.
71. A prospective cohort study of smoking in acute pancreatitis / B. Lindkvist, S. Appelros, J. Manjer [et al.] // Pancreatology. – 2008. – Vol. 8. – P. 63–70.
72. A prospective study of pancreatic cancer in the elderly / A. Shibata, T. M. Mack, A. Paganini-Hill [et al.] // Int. J. Cancer. – 1994. – Vol. 58, No 1. – P. 46–49.
73. Proteomic analysis of chronic pancreatitis and pancreatic adenocarcinoma / T. Crnogorac-Jurcevic, R. Gangeswaran, V. Bhakta [et al.] // Gastroenterology. ― 2005. ― Vol. 129. ― P. 14541463.
74. Rectal nonsteroidal anti-inflammatory drugs are superior to pancreatic duct stents in preventing pancreatitis after endoscopic retrograde cholangiopancreatography : a network meta-analysis / A. Akbar, B. K. Abu Dayyeh, T. H. Baron [et al.] // Clin. Gastroenterol. Hepatol. – 2013. – Vol. 11. – P. 778–783.
75. The recurrence of acute alcohol-associated pancreatitis can be reduced : a randomized controlled trial / I. Nordback, H. Pelli, R. Lappalainen-Lehto [et al.] // Scand. J. Gastroenterology. – 2009. – Vol. 136. – P. 848–855.
76. Recurrent flares of pancreatitis predict development of exocrine insufficiency in chronic pancreatitis / B. S. Sandhu, W. A. Hackworth, S. Stevens [et al.] // Clin. Gastroenterol. Hepatol. – 2007. – Vol. 5, No 9. – P. 1085–1091.
77. Risk of acute pancreatitis in type 2 diabetes and risk reduction on anti-diabetic drugs: a population-based cohort study in Taiwan / S. W. Lai, C. H. Muo, K. F. Liao [et al.] // Am. J. Gastroenterol. – 2011. – Vol. 106. – P. 1697–1704.
78. The risk of cancer among patients with cystic fibrosis. Cystic Fibrosis and Cancer Study Group / J. P. Neglia, S. C. FitzSimmons, P. Maisonneuve [et al.] // N. Engl. J. Med. ― 1995. ― Vol. 332. ― P. 494499.
79. Risk of pancreatic adenocarcinoma in chronic pancreatitis / D. Malka, P. Hammel, А. Maire [et al.] // Gut. ― 2002. ― Vol. 51. ― P. 849852.
80. Rulyak S. J. Inherited pancreatic cancer: improvements in our understanding of genetics and screening / S. J. Rulyak, T. A. Brentnall // Int. J. Biochem. Cell. Biol. ― 2004. ― Vol. 36. ― P. 13861392.
81. Sakofaras G. H. Pancreatic cancer after surgery for chronic pancreatitis / G. H. Sakofaras, M. G. Sarr // Dig. Liver Dis. ― 2003. ― Vol. 35. ― P. 482485.
82. Smoking and body mass index and survival in pancreatic cancer patients / C. Pelucchi, C. Galeone, J. Polesel [et al.] // Pancreas. – 2014. – Vol. 43, No 1. – P. 47–52.
83. Smoking and risk of acute and chronic pancreatitis among women and men : a population-based cohort study / J. S. Tolstrup, L. Kristiansen, U. Becker, M. Gronbaek // Arch. Intern. Med. – 2009. – Vol. 169. – P. 603–609.
84. Yadav D. The epidemiology of pancreatitis and pancreatic cancer / D. Yadav, A. B. Lowenfels // Gastroenterology. – 2013. – Vol. 144. – P. 1252–1261.
85. Zheng M. H. Rectal administration of NSAIDs in the prevention of post-ERCP pancreatitis : a complementary meta-analysis / M. H. Zheng, H. H. Xia, Y. P. Chen. – Gut. – 2008. – Vol. 57. – P. 1632–1633.
2. Корочанская Н. В. Хирургическая и медикаментозная профилактика раковой трансформации хронического панкреатита / Н. В. Корочанская, М. Л. Рогаль, И. Ю. Гришина. ― М. : 4ТЕ АРТ, 2008. ― 56 с.
3. Мудрые мысли о медицине и врачевании: изречения, афоризмы, цитаты / автор композиции Я. С. Циммерман. – 4-е изд., доп. – М. : ГЭОТАР-Медиа, 2015. – 256 с.
4. Практическая гепатология / под ред. акад. РАМН Н. А. Мухина // Материалы «Школы гепатолога», проводимой на базе клиники нефрологии, внутренних и профессиональных заболеваний им. Е. М. Тареева ММА им. И. М. Сеченова. – М., 2004. – 294 с.
5. Alcohol and cigarette smoke components activate human pancreatic stellate cells: implications for the progression of chronic pancreatitis / A. T. Lee, Z. Xu, S. P. Pothula [et al.] // Alcohol. Clin. Exp. Res. – 2015. – Vol. 39, No 11. – P. 2123–2133.
6. Alcohol consumption and site-specific cancer risk : a comprehensive dose-response meta-analysis / V. Bagnardi, M. Rota, E. Botteri [et al.] / Br. J. Cancer. –2015. – Vol. 112, No 3. – P. 580–593.
7. Alcohol intake and pancreatic cancer : a pooled analysis from the pancreatic cancer cohort consortium (PanScan) / D. S. Michaud, L. Jiao [et al.] // Cancer Causes Control. – 2010. – Vol. 21, No 8. – P. 1213–1225.
8. And the American College of Gastroenterology. American College of Gastroenterology guideline : management of acute pancreatitis / S. Tenner, J. Baillie, J. DeWitt, S. S. Vege // Am. J. Gastroenterol. – 2013. – Vol. 108. – P. 1400–1416.
9. And the European Society of Gastrointestinal Endoscopy. European Society of Gastrointestinal Endoscopy (ESGE) Guideline: prophylaxis of post-ERCP pancreatitis / J. M. Dumonceau, A. Andriulli, J. Deviere [et al.] // Endoscopy. – 2010. – Vol. 42. – P. 503–515.
10. And the U.S. Cooperative for Outcomes Research in Endoscopy (USCORE). A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis / B. J. Elmunzer, J. M. Scheiman, G. A. Lehman [et al.] // N. Engl. J. Med. – 2012. – Vol. 366. – P. 1414–1422.
11. Apte M. Pancreatic stellate cell: physiologic role, role in fibrosis and cancer / M. Apte, R. C. Pirola, J. S. Wilson // Curr. Opin. Gastroenterol. – 2015. – Vol. 31, No 5. – P. 416–423.
12. Aspects of medical history and exocrine carcinoma of the pancreas: a population-based case-control study in the Netherlands / H. B. Bueno de Mesquita, P. Maisonneure, C. J. Moerman, A. M. Walker // Int. О. Cancer. ― 1992. ― Vol. 52. ― P. 1723.
13. Augustine P. Is tropical pancreatitis premalignant? / P. Augustine, H. Ramesh // Am. J. Gastroenterol. ― 1992. ― Vol. 87. ― P. 10051008.
14. Brentnall T. A. Management strategies for patients with hereditary pancreatic cancer / T. A. Brentnall // Curr. Treat. Options Oncol. ― 2005. ― Vol. 6. ― P. 437445.
15. Burden of gastrointestinal disease in the United States : 2012 update / A. F. Peery, E. S. Dellon, J. Lund [et al.] // Gastroenterology. – 2012. – Vol. 143. – P. 1179–1187, e1–3.
16. Cachexia in patients with chronic pancreatitis and pancreatic cancer: impact on survival and outcome / J. Bachmann, M. W. Buchler, H. Friess, M. E. Martignoni // Nutr. Cancer. – 2013. – Vol. 65, No 6. – P. 827–833.
17. Cancer risk in nontransplanted and transplanted cystic fibrosis: a 10-year study / P. Maisonneuve, S. C. FitzSimmons, J. P. Neglia [et al.] // J. Natl. Cancer Inst. ― 2003. ― Vol. 95. ― P. 381387.
18. Can early precut implementation reduce endoscopic retrograde cholangiopancreatography-related complication risk? Meta-analysis of randomized controlled trials / V. Cennamo, L. Fuccio, R. M. Zagari [et al.] // Endoscopy. – 2010. – Vol. 42. – P. 381–388.
19. Cardiovascular risk (CVR) associated with pancreatic exocrine insufficiency (PEI) in patients with chronic pancreatitis / N. Vallejo-Senra, De la Inglesia-Garsia, A. Lopez-Lopez [et al.] // Pancreatology. – 2016. – Vol. 16, No 3S1. – P. S80.
20. Cigarette smoking accelerates progression of alcoholic chronic pancreatitis / P. Maisonneuve, A. B. Lowenfels, B. Mullhaupt [et al.] // Gut. ― 2005. ― Vol. 54, No 4. ― P. 510–514.
21. Cigarette smoking, smoking cessation and acute pancreatitis : a prospective population-based study / O. Sadr-Azodi, A. Andren-Sandberg, N. Orsini, A. Wolk // Gut. – 2012. – Vol. 61. – P. 262–267.
22. Complications of single-balloon enteroscopy : a prospective evaluation of 166 procedures / H. Aktas, L. de Ridder, J. Haringsma [et al.] // Endoscopy. – 2010. – Vol. 42. – P. 365–368.
23. A critical analysis of the clinical use of incretin-based therapies: are the GLP-1 therapies safe? / P. C. Butler, M. Elashoff, R. Elashoff, E. A. Gale // Diabetes Care. – 2013. – Vol. 36. – P. 2118–2125.
24. Cystic fibrosis transmembrane regulator (CFTR) DeltaF508 mutation and ST allele in patients with chronic pancreatitis and exocrine pancreatic cancer. PANKRAS II Study Group / N. Malats, T. Casals, M. Porta [et al.] // Gut. ― 2001. ― Vol. 48. ― P. 7074.
25. Cystic fibrosis transmembrane regulator gene carrier status is a risk factor for young onset pancreatic adenocarcinoma / R. McWilliams, W. E. Highsmith, K. G. Rabe [et al.] // Gut. ― 2005. ― Vol. 54. ― P. 16611662.
26. Dai H. F. Role of nonsteroidal anti-inflammatory drugs in the prevention of post-ERCP pancreatitis : a meta-analysis / H. F. Dai, X. W. Wang, K. Zhao // Hepatobiliary Pancreat. Dis. Int. – 2009. – Vol. 8. – P. 11–16.
27. The different courses of early- and late-onset idiopathic and alcoholic chronic pancreatitis / P. Layer, H. Yamamoto, L. Kalthoff [et al.] // Gastroenterology. ― 1994. ― Vol. 107, No 5. ― P. 1481–1487.
28. DiMagno M. J. Pancreas divisum does not cause pancreatitis, but associates with CFTR mutations / M. J. DiMagno, E. P. Dimagno // Am. J. Gastroenterol. – 2012. – Vol. 107. – P. 318–320.
29. Disease progression of acute pancreatitis in pediatric patients / F. Hao, H. Guo, Q. Luo, C. Guo // J. Surg. Res. – 2016. – Vol. 202, No 2. – P. 422–427.
30. Dominguez-Munoz J. E. Survival of patients with unresectable pancreatic cancer: impact of the treatment of pancreatic exocrine insufficiency and malnutrition / J. E. Dominguez-Munoz, L. Nieto, J. Iglesias-Garcia // Pancreatology. – 2013. – Vol. 13, Issue 4. – P. e5.
31. Drug-induced pancreatitis // C. Nitsche, S. Maertin, J. Scheiber [et al.] // Curr. Gastroenterol. Rep. – 2012. – Vol. 14. – P. 131–138.
32. European Registry of Hereditary Pancreatitis and Pancreatic Cancer (EUROPAC). Clinical and genetic characteristics of hereditary pancreatitis in Europe / N. Howes, M. M. Lerch, W. Greenhalf [et al.] // Clin. Gastroenterol. Hepatol. ― 2004. ― Vol. 2. ― P. 5261.
33. Exocrine and endocrine pancreatic insufficiency after acute pancreatitis / M. Vujasinovic, B. Tepes, J. Makuc [et al.] // Pancreatology. – 2013. – Vol. 13, No 3S. – P. S65.
34. For the Dutch Pancreatitis Study Group. Timing of cholecystectomy after mild biliary pancreatitis / O. J. Bakker, H. C. van Santvoort, J. C. Hagenaars [et al.] // Brit. J. Surg. – 2011. – Vol. 98. – P. 1446–1454.
35. Frequency of K-ras mutations in pancreatic intraductal neoplasias associated with pancreatic ductal adenocarcinoma and chronic pancreatitis : a meta-analysis / M. Lohr, G. Kloppel, P. Maisonneuve [et al.] // Neoplasia. ― 2005. ― Vol. 7. ― P. 1723.
36. Gallstones, cholecystectomy and risk of cancers of the liver, biliary tract and pancreas / W. H. Chow, C. Johansen, G. Gridley [et al.] // Br. J. Cancer. –1999. –Vol. 79, No 3–4. – P. 640–644.
37. Garg P. K. Is biliary microlithiasis a significant cause of idiopathic recurrent acute pancreatitis? A long-term follow-up study / P. K. Garg, P. K. Tandon, K. Madan // Clin. Gastroenterol. Hepatol. – 2007. – Vol. 5, No 1. – P. 75–79.
38. Gotian A. Pancreatitis associated with Crohn's disease: a premalignant state for cystadenocarcinoma of pancreas? / A. Gotian, S. Katz // Am. J. Gastroenterol. – 1999. – Vol. 94, No 8. – P. 2301–2302.
39. Gradirian P. Tobacco, alcohol, and coffee and саncer of the pancreas. A population-based, case-control study in Quebec, Canada / P. Gradirian, A. Simard, J. Baillargeon // Cancer. ― 1991. ― Vol. 67. ― P. 26642670.
40. Gullo L. Effect of cessation of alcohol use on the course of pancreatic dysfunction in alcoholic pancreatitis / L. Gullo, L. Barbara, G. Labo // Gastroenterology. ― 1988. ― Vol. 95, No 4. ― P. 1063–1068.
41. Heavy smoking is associated with lower age at first episode of acute pancreatitis and a higher risk of recurrence / S. Munigala, D. L. Conwell, A. Gelrud, B. Agarwal // Pancreas. – 2015. – Vol. 44, No 6. – P. 876–881.
42. Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group / A. B. Lowenfels, P. Maisonneuve, E. P. DiMango [et al.] // J. Natl. Cancer Inst. ― 1997. ― Vol. 89. ― P. 442446.
43. Incidence of cancer in the course of chronic pancreatitis / G. Talamini, M. Falconi, C. Bassi [et al.] // Am. J. Gastroenterol. ― 1999. ― Vol. 94. ― P. 12531260.
44. Increased risk of acute pancreatitis and biliary disease observed in patients with type 2 diabetes : a retrospective cohort study / R. A. Noel, D. K. Braun, R. E. Patterson, G. L. Bloomgren // Diabetes Care. – 2009. – Vol. 32. – P. 834–838.
45. Increased risk of acute pancreatitis in patients with type 2 diabetes : an observational study using a Japanese hospital database / H. Urushihara, M. Taketsuna, Y. Liu [et al.] // PLoS One. – 2012. – Vol. 7. – P. e53224.
46. Indomethacin treatment of acute experimental pancreatitis in the rat / P. G. Lankisch, H. Koop, K. Winckler [et al.] // Scand. J. Gastroenterol. – 1978. – Vol. 13. – P. 629–633.
47. Indomethacin treatment of acute pancreatitis. A controlled double-blind trial / N. Ebbehoj, J. Friis, L. B. Svendsen [et al.] // Scand. J. Gastroenterol. – 1985. – Vol. 20. – P. 798–800.
48. Insulin dependence and pancreatic enzyme replacement therapy are independent prognostic factors for long-term survival after operation for chronic pancreatitis / M. Winny, V. Paroglou, H. Bektas [et al.] // Surgery. – 2014. – Vol. 155, No 2. – P. 271–279.
49. Lankisch P. G. Acute pancreatitis / P. G. Lankisch, M. Apte, P. A. Banks // The Lancet. – 2015. – Vol. 386, No 9988. – P. 85–96.
50. Lankisch P. G. What is the risk of alcoholic pancreatitis in heavy drinkers? / P. G. Lankisch, A. B. Lowenfels, P. Maisonneuve // Pancreas. – 2002. – Vol. 25. – P. 411–412.
51. Lohr J. M. Synopsis of recent guidelines on pancreatic exocrine insufficiency / J. M. Lohr, M. R. Oliver, L. Frulloni // United Eur. Gastroenterol. J. – 2013. – Vol. 1, No 2. – Р. 79–83.
52. Long-term follow-up of patients with chronic pancreatitis and K-ras gene mutation detected in pancreatic juice / N. Furuya, S. Kawa, T. Akamatsu, K. Furihata // Gastroenterology. ― 1997. ― Vol. 113. ― P. 593598.
53. Lowenfels A. B. What is the risk of biliary pancreatitis in patients with gallstones? / A. B. Lowenfels, P. G. Lankisch, P. Maisonneuve. – Gastroenterology. – 2000. – Vol. 119. – P. 879–880.
54. Low incidence of hyperamylasemia after proximal double-balloon enteroscopy: has the insertion technique improved? / H. Aktas, P. B. Mensink, J. Haringsma, E. J. Kuipers // Endoscopy. – 2009. – Vol. 41. – P. 670–673.
55. Masclee Ad A.M. Pancreatic exocrine insufficiency after acute pancreatitis / Ad A. M. Masclee, T. Symersky // Asian Pacific digestive disease week 2005. Proceedings of a Solvay satellite symposium. – 27 September 2005. – Seoul, Korea. – P. 9–12.
56. Mortality in patients with chronic pancreatitis (CP) with and without exocrine pancreatic insufficiency (EPI) / N. Vallejo-Senra, J. Iglesias-Garcia, J. Larino-Noia [et al.] // Pancreatology. – 2015. – Vol. 15, Issue 3. – S12–S13.
57. Natural history of acute pancreatitis: a long-term population-based study / P. G. Lankisch, N. Breuer, A. Bruns [et al.] // Am. J. Gastroenterol. – 2009. – Vol. 104, No 11. – P. 2797–2805.
58. Nauck M. A. A critical analysis of the clinical use of incretin-based therapies: the benefits by far outweigh the potential risks / M. A. Nauck // Diabetes Care. – 2013. – Vol. 36. – P. 2126–2132.
59. Otsuki M. Chronic pancreatitis in Japan: epidemiology, prognosis, diagnostic criteria, and future problems / M. Otsuki // J. Gastroenterol. ― 2003. ― Vol. 38. ― P. 315326.
60. Pancreas – pathological practice and research / Ed. K. Suda. – Basel [et al.] : Karger, 2007. – 318 p.
61. Pancreas cancer and smoking, beverage consumption, and past medical history / T. M. Mack, M. C. Yu, R. Hanisch, B. E. Henderson // О. Natl. Cancer Inst. ― 1986. ― Vol. 76. ― P. 4960.
62. Pancreas divisum is not a cause of pancreatitis by itself but acts as a partner of genetic mutations / C. Bertin, A. L. Pelletier, M. P. Vullierme [et al.] // Am. J. Gastroenterol. – 2012. – Vol. 107. – P. 311–317.
63. Pancreatic carcinoma developing in chronic pancreatitis: a report of four cases / O. Haas, G. Guillard, P. Rat [et al.] // Hepatogastroenterology. ― 1990. ― Vol. 37. ― P. 350–351.
64. Pancreatic carcinoma in chronic pancreatitis with inflammatory tumor of the head of the pancreas / W. Schlosser, M. H. Schoenberg, E. Rhein [et al.] // Gastroenterol. ― 1996.― Vol. 34. ― P. 3–8.
65. Pancreatitis and the risk of pancreatic cancer / E. Fernandez, C. La Vecchia, M. Porta [et al.] // Pancreas. ― 1995. ― Vol. 11. ― P. 185189.
66. Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group / A. B. Lowenfels, P. Maisonneuve, G. Cavallini [et al.] // N. Engl. О. Med. ― 1993. ― Vol. 328. ― P. 14331437.
67. Patients with type 2 diabetes mellitus have higher risk for acute pancreatitis compared with those without diabetes / C. J. Girman, T. D. Kou, B. Cai [et al.] // Diabetes Obes. Metab. – 2010. – Vol. 12. – P. 766–771.
68. Predictive factors for pancreatic cancer in patients with chronic pancreatitis in association with K-ras gene mutation / M. Arvanitakis, J. L. Van Laethem, J. Parma [et al.] // Endoscopy. ― 2004. ― Vol. 36. ― P. 535542.
69. Prognosis of chronic pancreatitis : an international multicenter study. International Pancreatitis Study Group / A. B. Lowenfels, P. Maisonneuve, G. Cavallini [et al.] // Am. J. Gastroenterol. ― 1994. ― Vol. 89. ― P. 14671471.
70. Prophylactic pancreatic stent placement and post-ERCP pancreatitis : an updated meta-analysis / T. Mazaki, K. Mado, H. Masuda, M. Shiono // J. Gastroenterol. – 2013. – Vol. 49. – P. 343–355.
71. A prospective cohort study of smoking in acute pancreatitis / B. Lindkvist, S. Appelros, J. Manjer [et al.] // Pancreatology. – 2008. – Vol. 8. – P. 63–70.
72. A prospective study of pancreatic cancer in the elderly / A. Shibata, T. M. Mack, A. Paganini-Hill [et al.] // Int. J. Cancer. – 1994. – Vol. 58, No 1. – P. 46–49.
73. Proteomic analysis of chronic pancreatitis and pancreatic adenocarcinoma / T. Crnogorac-Jurcevic, R. Gangeswaran, V. Bhakta [et al.] // Gastroenterology. ― 2005. ― Vol. 129. ― P. 14541463.
74. Rectal nonsteroidal anti-inflammatory drugs are superior to pancreatic duct stents in preventing pancreatitis after endoscopic retrograde cholangiopancreatography : a network meta-analysis / A. Akbar, B. K. Abu Dayyeh, T. H. Baron [et al.] // Clin. Gastroenterol. Hepatol. – 2013. – Vol. 11. – P. 778–783.
75. The recurrence of acute alcohol-associated pancreatitis can be reduced : a randomized controlled trial / I. Nordback, H. Pelli, R. Lappalainen-Lehto [et al.] // Scand. J. Gastroenterology. – 2009. – Vol. 136. – P. 848–855.
76. Recurrent flares of pancreatitis predict development of exocrine insufficiency in chronic pancreatitis / B. S. Sandhu, W. A. Hackworth, S. Stevens [et al.] // Clin. Gastroenterol. Hepatol. – 2007. – Vol. 5, No 9. – P. 1085–1091.
77. Risk of acute pancreatitis in type 2 diabetes and risk reduction on anti-diabetic drugs: a population-based cohort study in Taiwan / S. W. Lai, C. H. Muo, K. F. Liao [et al.] // Am. J. Gastroenterol. – 2011. – Vol. 106. – P. 1697–1704.
78. The risk of cancer among patients with cystic fibrosis. Cystic Fibrosis and Cancer Study Group / J. P. Neglia, S. C. FitzSimmons, P. Maisonneuve [et al.] // N. Engl. J. Med. ― 1995. ― Vol. 332. ― P. 494499.
79. Risk of pancreatic adenocarcinoma in chronic pancreatitis / D. Malka, P. Hammel, А. Maire [et al.] // Gut. ― 2002. ― Vol. 51. ― P. 849852.
80. Rulyak S. J. Inherited pancreatic cancer: improvements in our understanding of genetics and screening / S. J. Rulyak, T. A. Brentnall // Int. J. Biochem. Cell. Biol. ― 2004. ― Vol. 36. ― P. 13861392.
81. Sakofaras G. H. Pancreatic cancer after surgery for chronic pancreatitis / G. H. Sakofaras, M. G. Sarr // Dig. Liver Dis. ― 2003. ― Vol. 35. ― P. 482485.
82. Smoking and body mass index and survival in pancreatic cancer patients / C. Pelucchi, C. Galeone, J. Polesel [et al.] // Pancreas. – 2014. – Vol. 43, No 1. – P. 47–52.
83. Smoking and risk of acute and chronic pancreatitis among women and men : a population-based cohort study / J. S. Tolstrup, L. Kristiansen, U. Becker, M. Gronbaek // Arch. Intern. Med. – 2009. – Vol. 169. – P. 603–609.
84. Yadav D. The epidemiology of pancreatitis and pancreatic cancer / D. Yadav, A. B. Lowenfels // Gastroenterology. – 2013. – Vol. 144. – P. 1252–1261.
85. Zheng M. H. Rectal administration of NSAIDs in the prevention of post-ERCP pancreatitis : a complementary meta-analysis / M. H. Zheng, H. H. Xia, Y. P. Chen. – Gut. – 2008. – Vol. 57. – P. 1632–1633.